WO2017129694A1
|
|
Nilotinib dinitrate (v) and crystalline forms thereof
|
WO2016116607A1
|
|
Process and intermediates for the racemization of enantiomerically enriched 1-aminoindane
|
WO2015091068A1
|
|
Crystalline forms of tapentadol intermediate
|
EP3083582A1
|
|
A new process for the preparation of candesartan cilexetil
|
WO2015014907A1
|
|
Process for preparation of tulathromycin
|
WO2015070995A1
|
|
Process for the preparation of enatiomerically pure 1-aminoindan
|
EA030553B1
|
|
Tapentadol maleate and crystalline forms thereof
|
WO2014096214A1
|
|
A process for preparation of rivaroxaban
|
EP2861316A1
|
|
Selective crystallization processes using reverse micelle and w/o microemulsion systems - multitask emulsion crystallization (mec)
|
WO2013037838A1
|
|
Polymorphic form of pitavastatin calcium
|
EP2736915A1
|
|
New crystalline forms of tulathromycin
|
EP2736909A1
|
|
Process for the preparation of sitagliptin and its pharmaceutically acceptable salts
|
EP2714676A1
|
|
A process for the preparation of polymorphic form i of etoricoxib
|